Dapsone | Teva UK
Teva Worldwide Product List
For members of the public:

Dapsone

Overview

Teva markets Dapsone. The Patient Information Leaflet for Dapsone from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) you can contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117.

Date of preparation: April 2023
D: COB-GB-NP-00112 (V1.0) / T: COB-GB-NP-00102 (V1.0) / M: COB-GB-NP-00103 (V1.0)

Date of preparation: April 2023
D: COB-GB-00016 (V1.0) / T: COB-GB-00014 (V1.0) / M: COB-GB-00015 (V1.0)

Date of preparation: April 2023
D: COB-GB-NP-00104 (V1.0) / T: COB-GB-NP-00105 (V1.0) / M: COB-GB-NP-00106 (V1.0)

Teva UK Limited

Teva's Product List

Please confirm if you are a member of the public, or a patient prescribed a Teva medicine by a UK healthcare professional (or their caregiver) or if you are UK healthcare professional.

Patients: The information on the patients website is suitable for and solely intended for UK patients prescribed a Teva medicine following consultation with a UK healthcare professional (or their caregiver). By selecting this button you are confirming that you are a patient who has been prescribed a Teva medicine by a UK healthcare professional (or their caregiver).

Healthcare professionals: The information on the UK healthcare professionals website is suitable for and solely intended for UK healthcare professionals. By selecting this button you are confirming that you are a UK healthcare professional.


Date of preparation: April 2023
D: COB-GB-NP-00109 (V1.0) / T: COB-GB-NP-00110 (V1.0) / M: COB-GB-NP-00111 (V1.0)